Last reviewed · How we verify
Oxycontine CR 10mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Oxycontine CR 10mg (Oxycontine CR 10mg) — GL Pharm Tech Corporation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oxycontine CR 10mg TARGET | Oxycontine CR 10mg | GL Pharm Tech Corporation | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oxycontine CR 10mg CI watch — RSS
- Oxycontine CR 10mg CI watch — Atom
- Oxycontine CR 10mg CI watch — JSON
- Oxycontine CR 10mg alone — RSS
Cite this brief
Drug Landscape (2026). Oxycontine CR 10mg — Competitive Intelligence Brief. https://druglandscape.com/ci/oxycontine-cr-10mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab